Exclusive weekly insights for sharemarket success.
Each week join Kien Trinh, Head of Research, and his team as they discuss all things sharemarket.
Tim Lincoln, Co-Founder and Chief Investment Officer, and Matt Swartz, Senior Portfolio Manager, will join the conversation once a month to share their passion and strategy for Lincoln Indicator’s Managed Funds, as well as their insights for investors.
In this edition of Taking Stock, Chief Investment Officer, Tim Lincoln, joins Head of Research, Kien Trinh to discuss market concerns surrounding the impact of the COVID Omicron variant. Tim highlights the continued strength of the Star Growth Stocks portfolio and provides a glimpse into the strategies within the Lincoln Australian and U.S. Funds.
Star stocks covered this week includes M&A activity from Codan (CDA), Adairs (ADH), Credit Corp Group (CCP) and GUD Holdings (GUD).
Question of the week looks at how investors can assess the impact of an acquisition to a business.
We hope you enjoy and find the video useful.
Experience Stock Doctor yourself by taking a FREE trial today.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.